As SkinCeuticals founding scientist and chief medical advisor, Dr. Sheldon Pinnell established SkinCeuticals as the skincare industry’s antioxidant authority. Dr. Pinnell’s groundbreaking, peer-reviewed research and comprehensive dermatologic knowledge resulted in the Duke University Antioxidant patent, which is now the gold standard for topical antioxidant formulations and licensed exclusively to SkinCeuticals.
But all clinical studies are not created equal. Some studies only look at one or two ingredients in a formulation. Others test these ingredients at concentrations much higher than the levels found in the final product. Even more, some studies are performed in-vitro, or in a petri dish as opposed to real, live skin.
At SkinCeuticals, we hold our clinical studies to the highest medical and pharmaceutical standards, and dermatologists oversee our testing. We perform biomarker studies to assess a final formulation’s action within the skin, as well as evaluate a product’s efficacy on actual patients’ skin. As a result, the findings of our clinical studies translate exactly to how our products perform when used in the real world, on real skin.
Our first clinical study on vitamin C paved the way for antioxidant formulation, and set SkinCeuticals on the path to becoming one of the skincare industry’s most respected product innovators. As one of the first companies to provide scientific evidence that supports its product benefits by publishing clinical studies in respected medical journals, SkinCeuticals continues to raise the bar for skin science. Since the first vitamin C study, SkinCeuticals has been behind some of the most pivotal skincare discoveries in recent history.
Pinnell, S.R., et al.,Topical L-Ascorbic Acid: Percutaneous Absorption Studies.
Dermatol Surg 27:2, 137-142, 2001
SkinCeuticals was the first to discover the exact formulation specifications a topical antioxidant must meet in order to penetrate—and protect—the skin. These parameters have become the gold standard for antioxidant formulation.
Pinnell, S.R, J Am Acad Dermatol. 48(1): 1-19, 2003.
In order to provide full-spectrum protection against environmentally caused skin damage, it is imperative to use a topical antioxidant daily. This added protection from free radicals has been proven to prevent cellular changes deep within the skin.
Haywood, R., et al, J Invest Dermatol 2006;121:862-868
Sunscreen is essential for shielding skin from UVA and UVB rays, but this pivotal SkinCeuticals study found that SPF alone only protects skin from up to 55% of damaging free radicals—and that the addition of a SkinCeuticals topical antioxidant provides comprehensive skin protection.
Pinnell, S. et al. J Am Acad Dermatol. 59(3):418-25, 2008.
With SkinCeuticals third-generation topical antioxidant, C E Ferulic, it is possible to provide the skin with eight times its natural photoprotection, as well as unprecedented anti-aging results.
Oresajo C, Stephens T, Hino PD, Law RM, Yatskayer M, Foltis P, Pillai S, Pinnell SR.
J Cosmet Dermatol. 2008 Dec;7(4):290-7.
With the addition of phloretin, SkinCeuticals antioxidants have been clinically proven to reverse premature signs of aging while protecting skin from free radicals and other reactive molecules that are known to cause DNA mutations.
SkinCeuticals holds its research, formulations, clinical testing, product quality, and corporate ethics to the highest standards. This commitment makes it possible to provide our patients and professional partners with advanced skincare that is backed by science, and proven to optimize skin health.